Roivant Sciences

Yahoo Finance • 4 days ago

Celcuity Stock Soars 700% in a Year as One Investor's $17 Million Buy Helps Create Top Two Position

On February 17, 2026, Perceptive Advisors reported a buy of Celcuity(NASDAQ:CELC), adding 203,881 shares in the fourth quarter, with an estimated transaction value of $16.76 million based on quarterly average pricing. What happened Accor... Full story

Yahoo Finance • 4 days ago

Apogee Shares Up Nearly 100% in 12 Months, and This $62 Million Buy Signals Ongoing Conviction

On February 17, 2026, Perceptive Advisors disclosed a buy of 978,662 shares of Apogee Therapeutics(NASDAQ:APGE), with an estimated transaction value of $61.64 million based on quarterly average pricing. What happened According to a Febru... Full story

Yahoo Finance • 13 days ago

Dolby Stock Down 18%, Yet This $8 Million Bet Signals Turnaround Potential

Key Points Neo Ivy Capital Management acquired 117,964 shares of DLB in the fourth quarter. The quarter-end stake value increased by $7.58 million due to the new shares acquired. DLB position accounts for 1.2% of fund AUM, placing it ins... Full story

Yahoo Finance • 20 days ago

Stocks Rebound on Positive Tech Earnings

The S&P 500 Index ($SPX) (SPY) today is up +1.20%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +1.48%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +1.26%.  March E-mini S&P futures (ESH26) are up +1.21%, and March E-mini Nasdaq fu... Full story

Yahoo Finance • 20 days ago

Wall Street Set to Open Modestly Higher Friday as Tech Stocks Stabilize Following Week-Long Rout

US equities look set to open slightly higher in Friday's trading session with tech stocks rebounding PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 21 days ago

Pulmovant Announces Completion of Enrollment in the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

PHocus enrollment completed in under 12 months from first patient dosed, representing a rapid enrollment pace in pulmonary hypertension associated with interstitial lung diseaseTopline results on track for second half of calendar year 2026... Full story

Yahoo Finance • 21 days ago

Stocks Settle Lower as Tech and Crypto are Routed

The S&P 500 Index ($SPX) (SPY) on Thursday closed down -1.23%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down -1.20%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -1.38%.  March E-mini S&P futures (ESH26) fell -1.23%, and... Full story

Yahoo Finance • 21 days ago

Pre-Market Earnings Report for February 6, 2026 : PM, CBOE, BIIB, AER, CG, CNC, NVT, ROIV, PAA, AN, MKTX, PIPR

The following companies are expected to report earnings prior to market open on 02/06/2026. Visit our Earnings Calendar for a full list of expected earnings releases. Philip Morris International Inc (PM)is reporting for the quarter end... Full story

Yahoo Finance • 24 days ago

Arbutus jumps on ruling in patent dispute with Moderna

[Vaccine patent file folder] oonal/iStock via Getty Images * Arbutus Biopharma (ABUS [https://seekingalpha.com/symbol/ABUS]) is up ~10% in Monday afternoon trading after a federal judge in Delaware determined that a patent dispute invol... Full story

Yahoo Finance • 2 months ago

Insider Confidence In December 2025's Leading Growth Companies

As the U.S. stock market continues to reach new heights, with the S&P 500 setting an all-time high and major indices logging consecutive gains, investors are increasingly attracted to companies that demonstrate robust growth potential and... Full story

Yahoo Finance • 3 months ago

Roivant Highlights Continued Pipeline Progress and Outlook for Company’s Next Phase of Growth at 2025 Investor Day

Roivant enters new phase of corporate journey with 3+ launches, 4+ NDA/BLA filings, 8+ pivotal and 3+ proof-of-concept study readouts expected over the next three yearsHighlighting clinical execution, Roivant announces positive updates to... Full story

Yahoo Finance • 3 months ago

Top Growth Companies With Strong Insider Ownership For November 2025

As the U.S. stock market experiences a significant upswing, with major indexes like the Nasdaq and S&P 500 posting notable gains, investors are keenly observing growth companies that exhibit strong insider ownership. In such a buoyant mark... Full story

Yahoo Finance • 4 months ago

Roivant Sciences GAAP EPS of -$0.17 beats by $0.16, revenue of $1.57M misses by $5.35M

* Roivant Sciences press release [https://seekingalpha.com/pr/20300059-roivant-reports-financial-results-for-the-second-quarter-ended-september-30-2025-and-provides] (ROIV [https://seekingalpha.com/symbol/ROIV]): Q2 GAAP EPS of -$0.17 be... Full story

Yahoo Finance • 4 months ago

Roivant Reports Financial Results for the Second Quarter Ended September 30, 2025, and Provides Business Update

Roivant Sciences BASEL, Switzerland and LONDON and NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today reported its financial results for the second quarter ended September 30, 2025, and provided a business update. B... Full story

Yahoo Finance • 4 months ago

Pre-Market Earnings Report for November 10, 2025 : B, B, TSN, ROIV, KSPI, TSEM, MNDY, CART, STWD, RDNT, BEKE, BXSL

The following companies are expected to report earnings prior to market open on 11/10/2025. Visit our Earnings Calendar for a full list of expected earnings releases. Barrick Mining Corporation (B)is reporting for the quarter ending Se... Full story

Yahoo Finance • 4 months ago

Roivant Sciences Q2 2026 Earnings Preview

* Roivant Sciences (ROIV [https://seekingalpha.com/symbol/ROIV]) is scheduled to announce Q2 earnings results on Monday, November 10th, before market open. * The consensus EPS Estimate is -$0.30 [https://seekingalpha.com/symbol/ROIV/ea... Full story

Yahoo Finance • 4 months ago

argenx SE beats top-line and bottom-line estimates; reaffirms FY25 outlook

* argenx SE press release [https://seekingalpha.com/pr/20285593-argenx-reports-third-quarter-2025-financial-results-and-provides-business-update] (ARGX [https://seekingalpha.com/symbol/ARGX]): Q3 GAAP EPS of $5.18 beats by $0.83. * Rev... Full story

Yahoo Finance • 4 months ago

Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025

NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Immunovant (Nasdaq: IMVT) today announced that it will report its financial results for the second quarter ended September 30, 2025, and provide a business update at 8:00 a.m. ET on Monday, Nov... Full story

Yahoo Finance • 4 months ago

Roivant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025

BASEL, Switzerland and LONDON and NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Monday, November 10, 2025, to report its financi... Full story

Yahoo Finance • 4 months ago

Wall Street Has a Mixed Opinion on Roivant Sciences Ltd (ROIV)

​Roivant Sciences Ltd. (NASDAQ:ROIV) is one of the Best Growth Stocks Under $25 to Buy Right Now. Wall Street has a mixed opinion on Roivant Sciences Ltd. (NASDAQ:ROIV) since the company announced positive results from its Phase 3 VALOR st... Full story